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1. Introduction 
Natural rubber latex (NRL) is a milky fluid from the Hevea brasiliensis (Hev b) tree, which  
functions as a protective sealant (Ownby, 2002). Because of its excellent elastic properties, it 
is widely used in the manufacture of medical devices and in a variety of everyday articles 
such as gloves, condoms, balloons, baby nipples, syringe plungers, and vial stoppers. As 
many as 40 000 types of consumer products may contain NRL (Perkin et al., 2000). The use 
of rubber for surgical gloves was first made in 1984 by Richard Cook and who popularized 
the use of rubber gloves in surgery was William Hasted (Dyck, 2000).  
NRL allergy is a common occupational disease. The induction of latex allergy commonly 
occurs after exposure of skin or mucous membrane to natural rubber latex. It is usually a 
contact dermatitis or delayed allergy (type IV), and reaction mediated by IgE (type I) or 
immediate hypersensitivity. Latex allergy symptoms can be mild or severe and manifest as 
contact urticaria, rhinoconjunctivitis, asthma, and mucosal swelling; systemic reactions 
consist of generalized urticaria and anaphylactic shock (Hamann et al., 1998; Agarwal & 
Gawkrodger, 2002; Cao et al., 2010; Cleenewerck, 2010). 
It affects people who are frequently exposed to products made of natural rubber latex, such 
as health care workers HCWs (5 to 17%); and groups at high risk included spina bifida 
cystica patients (to almost 65%), latex industry workers, specific food-allergy patients, and 
patients with a history of atopy or multiple surgical procedures (Nettis et al., 2002; 
Turjanmaa et al., 2002; Sullivan, 2005; Sukekava & Sell, 2007; Armentia et al., 2010; Bains et 
al., 2010; Radauer et al., 2011).  
Knowledge about latex allergy is important for three reasons: firstly, it is potentially fatal if 
the patient is not properly managed; secondly, it is common in healthcare workers (HCWs) 
as an occupational disease; and thirdly, its incidence has been increasing due to increased 
use of latex gloves as a barrier against viral infections (Agarwal & Gawkrodger, 2002). Also, 
latex has cross reactivity to banana, avocado, kiwi and other foods. 
Undiagnosed latex allergy is potentially very serious for patients and is increasingly 
recognized as a significant contributor to morbidity and mortality during medical and 
surgical procedures, and anaphylactic shock has been documented (Kosti & Lambrianidis, 
2002; Sonofuchi et al., 2010).  
At present, latex avoidance is the only available treatment and is the key to preventing 
allergic reactions in latex-sensitized individuals.  
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2. Latex allergens 
Latex products are ubiquitous in our environment and its use and choice is attributed to its 
biomechanical performance characteristics, which include strength, elasticity, tear 
resistance, and superior barriers qualities. 
Raw latex is a milky sap harvested from the rubber tree (Hevea brasiliensis) and it is 
subsequently vulcanized into elastic rubber with which we are all familiar. This milky 
substance is the cytoplasm of the cells of the lactiferous system of the tree. The vast majority 
of Hevea brasiliensis cultivation occurs in Malaysia, Indonesia and Thailand. After harvest by 
sap collection, NRL is ammoniated to prevent bacterial contamination and coagulation, 
resulting in the hydrolysis to latex proteins. Prior to use in manufacturing, the latex is 
formulated by the addition of multiple chemicals: accelerators, antioxidants, and secondary 
preservatives. Thus human exposure is a mixture of residual chemicals and hydrolyzed 
latex peptides. The proteins components have been responsible for type I latex-specific 
allergy and the accelerators and antioxidants are agents of type IV allergic reactions (contact 
dermatitis). Not until Charles Goodyear developed the process of vulcanization to stabilize 
rubber and prevent it from easily melting or freezing, did the rubber industry become 
important (Dyck, 2000). 
The essential structural functional unit in processed latex is an aqueous elastomer emulsion 
containing mainly cis-1,4-polyisoprene (30%-40%) and water (55%-65%), which is coated 
with a layer of protein, lipid, and phospholipids. The protein content of rubber tree sap is 
approximately 15mg/ml and includes more than 240 polypeptides, and 60 of these react to 
latex-specific IgE. Latex proteins can be divided into: water-soluble proteins, starch-bound 
proteins, and latex-bound proteins. Of the multiple proteins found in latex, certain specific 
proteins have been identified as being the major concern in causing IgE-mediated allergic 
reactions. Fourteen proteins have been identified, characterized, and officially accepted as 
allergenic components (Sussman & Beezold, 1994; Lee et al., 2010; Ott et al., 2010).  
The WHO_International Union of Immunological Societies Allergen Nomenclature 
Committee (www.allergens.org) listed 14 NRL Hev b allergens (Hev b 1-14) characterized at 
the molecular level.  It has included Hev b 1, rubber elongation factor (Chen et al., 1997); 
Hev b 2, b-1,3-glucanase (Yagami et al., 2002); Hev b 3, small rubber particle protein - a 24-
kDa protein (Wagner et al., 1999); Hev b 4, a component of the microhelix protein complex – 
lecithinase  homologue; Hev b 6, prohevein/hevein precursor; Hev b 7; patatin-like protein; 
and Hev b 13, esterase (Beirnstein et al., 2003); Hev b 5, acidic protein – proline-rich protein 
(Slater et al., 1996); Hev b 8, profiling (Nieto et al., 2002); Hev b 9, enolase (Wagner et al., 
2000); Hev b 10, manganese superoxide dismutase (Rihs et al., 2001); Hev b 12, non-specific 
lipid transfer protein 1 (Beezhold et al., 2003); and Hev b 11, class I chitinase, and  Hev b 14, 
hevamine, that no allergenicity has been described yet. The epitopes identified as IgE-
binding areas have been defined (Pedraza-Escalona et al., 2009; Rougé et al., 2010). Natural 
rubber latex (NRL) allergenic proteins are listed in Table 1. 
It has been suggested that Hev b 1 and Hev b 3 are major allergens in children with spina 
bifida and urological congenital anomalies (Baur et al., 1995; Yeang et al., 1996; Chen et al., 
1997). Berstein et al. (2003) identified Hev b 2, 5, 6.01 and Hev b 13 as the major in vivo 
allergens among HCWs with allergy to NRL, confirmed by percutaneous sensitivity to 
nonammoniated latex (NAL). These differences of epitopes reactivity can be explained by 
the different allergen profiles on internal and external surfaces of natural rubber latex gloves 
(Peixinho et al., 2008). 
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 Allerginicity  
 reference 
Rubber elongation factor Hev b 1 14 mainly associated with spina 
bifida patients  
Chen et al., 1997 
b-1,3-glucanase  Hev b 2 34 linked more to adult latex-allergy 
patients 
Yagami et al., 2002 
Small rubber particle 
protein 
Hev b 3 24 mainly associated with spina 
bifida patients 
Wagner et al., 1999 
Lecithinase homologue Hev b 4 53-55  Beirnstein et al., 
2003 
Acidic protein  Hev b 5 16 linked more to adult latex-allergy 
patients 
Slater et al., 1996 
Hevein precursor Hev b 6 20 linked more to adult latex-allergy 
patients 
Beirnstein et al., 
2003 
Patatin-like protein Hev b 7 42  Beirnstein et al., 
2003 
Profilin Hev b 8 15  Nieto et al., 2002 
Enolase  Hev b 9 51  Wagner et al., 2000 
Superoxide dismutase 
(Mn)  
Hev b 10 26  Rihs et al., 2001 
Class I chitinase Hev b 11 30 no allergenicity described   
Non-specific lipid 
transfer protein 1  
Hev b 12 9  Beezhold et al., 
2003 
Esterase Hev b 13 42 linked more to adult latex-allergy 
patients 
Beirnstein et al., 
2003 
Hevamine Hev b 14 30 no allergenicity described   
Table 1. Natural rubber latex (NRL) allergenic proteins 
3. Hypersensitivity reactions  
Specific immune responses are normally stimulated when an individual is exposed to a 
foreign antigen and this process is called immunization. Immune responses are specific for 
different structural components of the most complex proteins and polysaccharides antigens. 
The portions of such antigens are specifically recognized by distinct lymphocytes are called 
epitopes. This fine specificity exists because T and B lymphocytes express membrane 
receptors that distinguish subtle difference between distinct antigens. Naïve lymphocytes are 
continually released from the primary lymphoid organs into the periphery (secondary 
lymphoid organs). Antigen-binding can lead to activation of a T or B cell. All of the progeny 
cells derived from any single naïve lymphocytes that constitute a clone. 
Responses to most immunogens can begin only after the immunogen has been captured, 
processed, and presented by an APC (antigen-processing cell) to CD4 T cells (TH0). The 
reason of this is that T cells only recognize immunogens that are bound to major 
histocompatiblity complex (MHC) proteins on the surfaces of other cells. There are two 
different classes of MHC proteins. Class I MHC proteins are expressed virtually by all 
somatic cell types and are used to present substances to CD8 T cells, most of which are 
cytotoxic T cells. Class II MHC proteins, on the other hand, are expressed only by 
macrophages and a few other cells types and are necessary for antigen presentation to CD4 
T cells - the subset that includes most helper cells. Since helper-cell activation is necessary 
www.intechopen.com
 
Allergic Diseases – Highlights in the Clinic, Mechanisms and Treatment 
 
292 
for virtually all responses, the class II-bearing APCs plays a pivotal role in controlling such 
responses.  
Exogenous immunogens can be captured in a variety of ways. After captured by APCs 
become enclosed within membrane-lined vesicles in the cytoplasm and, within these 
vesicles, undergo a series of alterations called antigen processing and a limited number of 
the resulting peptides associated non-covalently with class II MHC proteins and transported 
to APC surface, where they can be detected by CD4 T cells. This process is called antigen 
presentation. At specific antigen recognition the sequences of events induced in 
lymphocytes initiate the activation phase. First, the lymphocyte proliferate, leading to 
expansion of the clones of antigen-specific lymphocytes and amplification of the protective 
response. Second, lymphocytes differentiate to cells that functions are to eliminate foreign 
antigens: thus, B cells transform to plasma cells that secret specific antibody that binds to 
soluble antigen; and some T cells (CD4 or T helper) differentiate into cells that activate 
phagocytes to kill intracellular antigens, and other T cells (CD8) that directly lyses cells that 
are producing foreign antigens such as viral proteins. The effector phase is the stage that 
activated performs the functions that lead to elimination of the antigens: inflammatory 
response is amplified after recruitment of specific and nonspecific effectors cells 
(lymphocytes, macrophages, basophiles, mast cells) and their soluble components 
production (lymphokines, monokines, complement, kinines, arachidonic acid derivates, and 
mast cells- basophile products).  
The immune response serves to protect the individual from foreign antigens with a well-
controlled immune and inflammatory response. However damage to host tissues and 
diseases can result from dysfunction of any component of the host defense system, like 
hypersensitivity or allergy. 
The allergy results when an exposure to the allergens induces an immune response, referred 
to as “sensitization” rather than immunization. Once sensitization occurs, an individual will 
be not symptomatic until there is a new exposure to the same allergen. Then the reaction of 
allergen with specific antibody or sensitized effector T lymphocyte induces an inflammatory 
response, producing the symptoms and signs of the allergic reaction. 
The reactions characteristic of type I hypersensitivity are dependent on the specific 
triggering of IgE-sensitized mast cell by allergen. The sensitization occurs when foreign 
antigens or allergens enter in the host, are processed and presented to APC to the T helper 2 
(TH2) cells. TH2 cells secrete cytokines (interleukins: IL-4, IL-5 and IL-6) that induces B cells 
proliferation and favour to production of an allergens specific-IgE response. IgE binds, via 
Fcε receptors, to mast cells and basophiles thus sensitizing them. When allergen 
subsequently reaches the sensitized mast cells it cross-links surphace-bound IgE and 
increases intracellular calcium that triggers the release of pre-formed mediators, such as 
histamine and proteases, and newly synthesized, lipid-derived mediators such as 
leukotrienes and prostaglandins. These autacoids produce the clinical symptoms of allergy 
(asthma, eczema, and anaphylaxis). 
Type IV (delayed) hypersensitivity reactions involve cell-mediated immune reactions rather 
than humoral response. The sensitization occurs when Langerhans cells process foreign 
antigens and present them to T helper 1 (TH1) cells. The T cells responsibly for the delayed 
response have been specifically sensitized by a previous encounter, and act recruiting other 
cell types to the site of the reaction. Contact hypersensitivity is characterized by an 
eczematous reaction at the point of the contact with an allergen. 
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4. Latex sensitization 
Sensitization and development of latex allergy arise from exposure to products containing 
residual latex proteins and chemical additives in latex products. Latex proteins are potent 
allergens capable of inducing fatal anaphylaxis. 
Sensitization of latex allergy can occur through the skin, by inhalation or by internal 
exposure (mucous membranes of the mouth, vagina or rectum). Medical devices (anesthetic 
masks, condom catheters, ileostomy bags, balloon catheters used for enemas and latex 
gloves) can induce sensitization and then subsequently cause an allergy to develop on re-
exposure. The addiction of cornstarch powder of gloves, in 1947, to prevent sticking and 
give a smoother fit, has been shown to increase the leaching of latex proteins and exposure 
latex proteins on the surface. Powder from latex gloves serves as vector of the dangerous 
proteins that then trigger an allergic response. Cornstarch also promotes aerosolization of 
the latex proteins when gloves are removed, and its release powder into the air and latex 
proteins are inhaled by all individuals in the room. Rubber is extensively distributed in the 
environment and we are in contact with it virtually all the time.  
Latex absorption through the skin is postulated as the major route of sensitization in health 
care workers by the soluble proteins. Friction, pressure, heat, and perspiration are among 
the nonspecific factors that influence the occurrence, severity, and sites of involvement of 
hypersensitivity and cutaneous manifestations. 
5. Pathogenesis and clinical manifestations 
Clinical manifestations include irritant contact dermatitis, allergic contact dermatitis (type 
IV), and immediate hypersensitivity reaction mediated by IgE (type I) (Table 2). It can affect 
the skin, eyes and lungs (Nutter, 1979; Hamann et al., 1998; Mebra & Hunter, 1998; Agarwal 
& Gawkrodger, 2002; Cao et al., 2010; Cleenewerck, 2010).  
5.1 Irritant contact dermatitis 
Irritant contact dermatitis (ICD) is not an allergic reaction. It occurs when an exogenous 
substance without previous sensitization causes direct damage to the skin. Usually it is the 
result of contact with glove additives. Chapped skin from hand washing can be responsible 
for this symptom. Early manifestations of this type of reaction include itchy (most common 
symptoms), but morphological features (dry, crusted lesions) are similar in allergic 
dermatitis, especially on fingers webs and under rings. Greater degrees of irritation result in 
burning, red or swollen tissues. Vesiculation is a late manifestation, but rarely occurs. ICD 
has a diagnosis for exclusion, and patch testing is negative. Management includes careful 
hand washing techniques, use of skin emollients, and an effective routine. 
5.2 Type IV hypersensitivity - Delayed reactions 
Delayed (type IV) allergy or contact dermatitis to rubber gloves is primarily caused by 
accelerators added to speed up rubber vulcanization, including carbamates, thiurams, 2-
mercaptobenzothiszole, and 1,3-diphenylguanidina. It may also cause by antioxidants that 
prevent rubber deterioration, such as black rubber mix chemicals (p-phenylenediamines 
(Cao et al., 2010). It typically manifests within 24 to 48 hours after contact with the allergen. 
It is localized to the skin or mucous membrane. The patient presents a diffuse or patchy 
eczema on the dorsal surface of the hands, wrists, and distal forearms. Latter the reaction 
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can become generalized, and chronic exposure leads to hyperkeratosis and lichenification, 
and at times either hyper- or hypopigmentation. The scalp and palms have a greater 
resistance to contact allergic and irritant reactions than other skin areas. The eyelids, penis, 
and scrotum often show erythema and edema rather than vesiculation. Patch testing is 
positive in these patients. The development of a type IV hypersensitivity allergic response 
may occur after years of contact with the substance. 
5.3 Type I hypersensitivity - Immediate reactions 
Type I reactions to latex involve specific immunoglobulin IgE and mediators of anaphylaxis. 
It is caused by latex proteins that direct sensitize the patients, and reactions occur within 1-
30 minutes. There may be a wide spectrum of clinical presentations. The route of latex 
antigen presentation will usually dictate the clinical manifestations. The skin manifestations 
include itching, swelling, localized pruritus and urticaria (direct contact). Respiratory 
involvement consists of sneezing, wheezing and rhinitis; and the eyes may water, itch and 
conjunctivitis (aerosol exposure or facial contact – latex proteins are adsorbed on gloves 
powder that becomes airborne and can be directly inhaled). A mucosal route of exposure to 
latex allergens is often associated with anaphylactic reactions. The clinical manifestations 
may be serious and give rise to a generalized shock-like reaction: systemic reactions such as 
broncospasm, hypotension, cardiorespiratory collapse, and shock can occur with more 
substantial exposure and in extremely sensitive individuals.  
Contact urticaria is the most common early manifestation of rubber allergy, particularly in 
latex-sensitive health care workers. Symptoms appear within 10-15 min after donning 
gloves. No residual coloration occurs after resolution of the urticaria. 
Anaphylactic shock is potentially fatal and anaphylactic response to latex exposure occurs 
most commonly intraoperatively. However, anaphylactic reactions have been encountered 
during gloving, exposure to dental dams, condom use, and even after indirect exposition by 
contact with individual who use latex gloves. The response appears minutes after the 
administration the allergen, manifesting as a respiratory distress, followed by vascular 
collapse and shock. Cutaneous symptoms, pruritus and urticaria, often occur with or 
without angioedema. Gastrointestinal manifestations involved nausea, vomiting, crampy 











Non-immunological Gloves additives 








produced by B cells
Latex proteins 
Type IV hypersensitivity  
Delayed reactions 
 
Contact dermatitis T cells sensitized to 
antigens 
Chemicals used in 
manufacture of 
latex 
Table 2. Pathogenesis and clinical manifestations to the allergy of latex 
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6. Incidence of latex allergy  
Latex allergy is now an important medical, occupational, medico-legal and financial 
problem, and it is essential that policies are developed to reduce it.  
The diffusion of the "universal precautions", promoted in 1987 by the Center for Disease 
Control and Prevention, dramatically increased the use of latex glove in health care workers 
(HCWs) to reduce the risk of infection, for protection against the HIV and HBV. The 
increased demand caused an increased production of gloves, and a different chemical 
treatment of rubber trees which lowered the glove quality, that means high levels of 
antigens and high powder content. This situation causes an increase of allergic frequency 
(type I and type IV) and irritant reactions to latex gloves in health care workers. 
The prevalence of latex allergy in the general population was estimated at 0.7%-1% in the 
most reports, but some reports now show numbers up to 6%.  A high prevalence of latex 
hypersensitivity is observed in certain occupational and other high-risk groups with 
frequent exposure to NRL products, including health care workers (ranges from 2.8% to 
17%), operating room personal (15-20%), rubber industry workers (near 10%), spina bifida 
cystica patients (to almost 65%), atopic individuals (7%), and those who have had multiple 
surgical operations (6.5%), patients with congenital urologic abnormalities, and those with a 
coexisting food allergy, most often related to certain fruits. The risk is associated with the 
peoples who are frequently exposed to products made of natural rubber latex such as in 
different regions, age, sex and ethnic groups. 
6.1 General population 
Although data is difficult to obtain, estimates now indicate that 1% to 6% of the general 
population has some sensitivity or allergy to latex. In 1994, Ownby et al. measured latex-
specific IgE in the serum from 1000 blood donors and 6.5% were positive. Prevalence of 
positive samples was not associated to race or age.  
6.2 Risk groups 
6.2.1 Health care workers 
The major source of workplace exposure has been powered natural rubber latex gloves used 
mainly by HCW. It has been a problem especially for HCW working in surgical areas or in 
places where  there is more use of latex gloves, in function of the high levels of airbone latex 
particles in these areas. The prevalence of immediate latex allergy increased with increasing 
duration of latex exposure. Studies have reported a prevalence of latex sensitization of from 
2.8 to 17% of the hospital workpopulation. 
The first scientific work describing dermatitis from rubber gloves was published in 1933 
(Downing, 1933). Nutter (1979) was the first investigator to describe contact urticaria to 
rubber gloves: the condition occurred in a house-wife with atopic dermatitis, and during the 
exacerbation of her hand eczema she noted intensive itching for her hands which occurred 5 
min after donning a pair of rubber gloves. The urticaria was confirmed by a patch test using 
a small piece of rubber gloves and with a skin prick test. One year later, Förström described 
the first case of contact urticaria from latex surgical gloves in a nurse with history of atopic 
dermatitis and allergic rhinitis. 
In 1987, Turjanmaa was the first to evaluate the frequency of latex gloves allergy among 
health care workers. A total of 512 hospital employees were screened by using a latex gloves 
scratch-chamber test and subsequent prick test for individuals who are positive in 
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screening. Twenty-three (4.5%) had positive scratch-chamber test, and the prick test was 
positive in 15 of these 23 patients. Most of them had a personal history of atopy, asthma, 
allergic rhinitis, and atopic eczema. Latex gloves allergy was significantly more frequent in 
personal of operative room. 
Arellano et al. (1992) were the first to report the prevalence of latex sensitization among 
physicians using latex gloves in a North American Hospital setting. Using a latex skin prick 
test they determined the sensitization in 9.9% of the North American physicians. 
Since 1987, the number of HCW with positive test results for NRL has been increased. In 
1994, Charous et al. reviewed medical histories of symptomatic workers with occupational 
exposure to latex and they evidenced that the number of patients reporting onset of latex-
induced contact dermatitis had remained relatively constant, whereas the number of the 
patients with contact dermatitis and systemic reactions had markedly increased.  
Some reports about prevalence of latex allergy in HCW in different countries are presented. 
At an Italy Hospital, a high prevalence of rubber glove-induced dermatoses among the 
employees were evidenced: about of 24% the health care workers, who used or had used 
latex gloves at work, reported glove-induced symptoms, namely, cutaneous symptoms in all 
the cases. Non-cutaneous symptoms appeared in 8.1%. Positive patch tests to rubber-related 
allergens were exhibited at 10.5% of symptomatic employees (Nettis et al., 2002). 
The prevalence of latex allergy among HCWs in Russia, and adjacent eastern European 
countries was available and considerably less than reported in Western Europe and the 
United States. Skin test to latex was positive in 5.4% of HCWs and 1.9% were classified as 
latex-allergic based on positive skin tests to latex associated with allergy symptoms with 
exposure. Some of them had experienced anaphylactic reactions to latex. The low prevalence 
of latex allergy suggests that lessened exposure to natural latex powdered gloves in HCWs 
in Russia (Nolte et al., 2002). 
To assess the allergic risk induced by latex gloves in HCWs, a meta-analysis was carried out 
under the auspices of the French National Regulatory Authority. Latex allergy was found in 
4.32% (range, 4.01% to 4.63%) of HCWs and in 1.37% (range, 0.43% to 2.31%) of the general 
population. Latex-positive skin prick test responses ranged from 2.1% to 3.7% in the general 
population and from 6.9% to 7.8% for the HCWs (Bousquet et al, 2006). 
To determine the main factors associated with latex allergy and to quantify levels of 
airborne latex particles in different areas of Spanish hospital, a cross-sectional study was 
conducted by Diéguez et al. (2007). More allergic patients were found in the surgery 
department, intensive care unit, and vascular radiology unit.  
In Taiwan, natural rubber latex is the most important occupational allergen among medical 
workers. To evaluate immediate latex allergy and contact dermatitis, 1253 medical workers 
were interviewed using a screening questionnaire and skin prick testing with commercial 
latex extract was performed. The prevalence of contact hand dermatitis from latex gloves 
was 35%. Twelve percent had positive latex skin prick test, suggesting that they had been 
sensitized to latex proteins. Seventy nine subjects (6%) had immediate allergic reactions to 
latex products (Lin et al., 2008).  
The prevalence of hypersensitivity to natural rubber latex and potential food cross reactions 
in operation room personnel in Shiraz hospitals revealed a significant correlation between 
those with positive skin tests to latex with atopia, urticaria, and food hypersensitivity. 
About 18% of operating room personnel showed positive latex skin tests. The prevalence 
did not vary by sex, age, education, surgical and non-surgical gloves users, or history of 
contact dermatitis (Nabavizadeh et al., 2009). 
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Dates from Asia countries with regard to latex allergy are scarce. Amarasekera et al. (2010) 
determined the prevalence and risk factors among healthcare workers in a hospital in Sri 
Lanka. Symptoms suggestive of latex allergy were reported in 16% of the subjects. A 
considerable proportion (11.4%) of workers had been suffering from latex allergy for more 
than 5 years.  
Oral health care professionals have been shown to be at risk for developing a type I allergy 
to natural rubber latex (NRL). The prevalence of this allergy in dental hygienists has been 
evaluated. Hamann et al. (2005) investigated by screened positive for a type I allergy to NRL 
(SPT-positive) 582 participants to 2000-2002 American Dental Hygienists' Association 
(ADHA) national meetings. Risk factors and symptom assessments were questioned and 
were based on a self-reported health history. About 5% screened positive for a type I allergy 
to NRL (SPT-positive). They observed that the NRL allergy was significantly more likely to 
report an allergy to cross-reacting foods, plants, moulds, and pollens, and to report reactions 
to rubber products. Sukekava & Sell (2007) determined the incidence of latex gloves allergy 
among dental care workers. Latex gloves reaction occurred in 19% of them, and 5% reported 
allergic reactions to other latex products; 2.5% reported symptoms suggesting contact 
dermatitis and anaphylaxis hypersensitivities, 1.5% reported contact dermatitis, and 1% 
reported anaphylaxis symptoms when wearing them. 
6.2.2 Latex industry workers 
Latex industry workers have an increased prevalence of chronic respiratory symptoms and 
reduced lung function. In 1988, Bascom et al. described a spectrum of respiratory illness 
associated with eosinophilia that occurred in a group of rubber workers exposed to fumes 
from a synthetic rubber-based curing operation. Two years latter, 81 latex industry workers 
were evaluated, and 7 had spirometric changes consistent with asthma, and two of them 
had positive skin prick test to latex. To known the relation of rubber tree dust exposure to 
respiratory and skin symptoms, asthma and lung function in regard  to wood dust from the 
rubber tree, a cross-sectional study was carried out among 103 workers in a rubber tree 
furniture factory and 76 office workers in four factories in Thailand. Factory workers 
showed increased risk of wheezing, nasal symptoms and asthma compared to office 
workers. There was a dose-dependent increase in wheeze and skin symptoms in regard to 
dust level. Significantly increased risks of nasal symptoms and asthma were detected in the 
low exposure category (Sripaiboonkij et al., 2009). 
6.2.3 Patients with spina bifida cystica 
Patients with spina bifida cystica form a population at highest risk of latex allergy. 
Management of infants with spina bifida cystica involves different procedures that include 
immediate operative skin closure of an open or thin walled defect, ventriculoperitoneal 
shunting of hydrocephalus, bracing of the lower extremities, and other surgical procedures 
to address sensory deficits, bowel and bladder dysfunction, pain elimination, orthopedic 
problems, and minimize or prevent associated neurologic defects. The major risk factors for 
latex sensitization in spina bifida cystica children include atopy, familiarity propensity for 
allergy, and very early exposure with mucosal absorption of allergen related to number of 
surgical procedures. Kelly et al. (1991) pointed out in their studies that spina bifida pediatric 
patients have 500 times greater a risk of latex-related anaphylaxis during operative 
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procedures than of the general pediatric population: eight of the 10 pediatric patients 
experiencing anaphylaxis during surgery. Prevalence of latex sensitivity among the spina 
bifida cystica pediatric population was among 40 to 65%. The recommendation is that 
children with spina bifida avoid contact with NRL products from birth.  
7. Cases reports of latex-induced anaphylactic reactions 
The prevalence of latex allergy is increasing in general population and surgical patient 
individuals. Several anaphylactic events during some surgical procedures are still rare; 
however they are associated with increased morbidity and mortality. Undiagnosed latex 
allergy is potentially very serious for patients. The risk factors for latex skin sensitization 
were: a previous history of atopy and asthma; history of surgery; pre-existing hand 
dermatitis; work-related symptoms; and positive skin tests to common inhalant and certain 
foods. Avoidance of exposure to the allergen is essential to minimizing preoperative 
complications in patients suspect to be at risk. 
In 2003, Verdolin et al. described an accidental diagnosis of latex allergy after urological 
surgery under spinal anesthesia when patient presented clinical manifestation of 
anaphylactic shock: confusion, dyspnea, generalized pruritus and erythema, bronchospasm, 
arterial hypotension, and tachycardia. In Japan, Ueda et al. (2008) reported an anaphylactic 
reaction to latex forty-three minutes subsequent to spinal anesthesia in a 46-year-old man 
with a history of atopic dermatitis and bronchial asthma underwent surgery for an inguinal 
hernia. Sonofuchi et al. (2010) reported anaphylactic shock after introduction of the general 
anesthesia in the patient who had latex allergy. Machado et al. (2011) described a case of 
severe latex induced anaphylactic reaction in a patient with a diagnostic suspicion of 
appendicitis who underwent an emergency surgery under spinal anesthesia. The symptoms 
occurred approximately 30 minutes after beginning the surgery. 
One of the groups that are at risk for anaphylactic reactions to latex during surgical and 
medical procedures is represented by the obstetric and gynecologic population. A case was 
reported when an anaphylactic reaction to latex occurred in a pregnant woman patient who 
underwent a caesarean section that the diagnosis of latex allergy was missed. Following day 
the woman underwent a surgical re-exploration complicated by fatal cardiovascular arrest. 
At post-mortem examination, pulmonary mast cells in the bronchial walls and capillary 
septa were identified, and a great number of degranulating mast cells with tryptase-positive 
material outside the cells was documented and the latex-specific IgE test showed a high title. 
Latex-induced fatal anaphylactic shock was recorded as the cause of death.  This case 
highlights some of the practical difficulties in the initial diagnosis and subsequent 
investigation of fatal anaphylactic reaction during anesthesia. Anaphylaxis is often 
misdiagnosed because many other pathologic conditions may present identical clinical 
manifestations, so anaphylactic shock must be differentiated from other causes of 
circulatory collapse. Although latex allergy usually has a delayed onset after the start of the 
surgery and most often a slow onset too, it should be always suspected if circulatory 
collapse and respiratory failure occur during surgery, even if the patient does not belong to 
a risk group; in the presence of identified risk factors for latex allergy a well-founded 
suspicion must be stronger, leading to an immediate discontinuation of the potential trigger 
(Turillazzi et al., 2008). 
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8. Immunological cross-reactivity between latex and other products 
8.1 Food cross-reactivity 
Latex allergy has been reported to be associated with allergy to certain foods. 
Approximately 30-50% of individuals who are allergic to natural rubber latex (NRL) show 
an associated hypersensitivity to some plant-derived foods, especially freshly consumed 
fruits. This association of latex allergy and allergy to plant-derived foods is called latex-fruit 
syndrome. An increasing number of plant sources have been associated with this syndrome. 
The most frequently involved are banana, avocado, kiwi, and chestnut, although several 
others may also be included as peach, grape, pineapple, nuts, figs, passion fruit, celery, 
citrus fruits, chestnut, peach, tomato, potato and bell pepper. Some studies have found out 
immunological and clinical cross-reactivity.  
The hypothesis is that allergen cross-reactivity is due to IgE antibodies that recognize 
structurally similar epitopes on different proteins that are phylogenetically closely related or 
represent evolutionarily conserved structures. Several types of proteins have been identified 
to be involved in the latex-fruit syndrome. Two of these are higher plant defense proteins. 
Class I chitinases containing an N-terminal hevein-like domain cross-react with hevein (Hev 
b 6.02). A beta-1,3-glucanase was identified as an important latex allergen which shows 
cross-reactivity with proteins of bell pepper and banana. Nine distinct IgE-binding epitopes 
were identified along the entire amino acid sequence of the major latex allergen Hev b 2 
(beta-1,3-glucanase), and a smaller number of IgE-binding epitopic areas was identified on 
the banana beta-1,3- glucanase, which exhibits a very similar overall conformation and 
charge distribution. Plant defense-related proteins are relatively conserved in the course of 
evolution and can supply cross-reactive epitopes. It is important to note that various stresses 
can stimulate the expression of these proteins, which implies that allergens increase in 
plants under stressful conditions like severe growing situations and exposure to some kinds 
of chemicals. Another important NRL allergen, Hev b 7, is a patatin-like protein that shows 
cross-reactivity with its analogous protein in potato (Wagner and Breiteneder, 2002; Barre et 
al., 2009).  
Axelsson e cols. were one of the first researches to described an association between latex 
allergy and fruit. They describe a 12-year-old girl who developed rhinoconjuntivitis and 
itching in the throat after eating stone fruits. Subsequently, she developed angioedema after 
inflating a rubber balloon (Woods et al., 1997). Recently, anaphylactic shock was related in a 
woman underwent a cardiac catheter examination, and a Swan-Ganz catheter was inserted. 
She declared no past history of latex allergy, but did have a banana allergy. Skin prick test 
showed a positive reaction to an extract of latex gloves an extract of the balloon of a Swan-
Ganz catheter (Sekiya et al., 2011). It is necessary to pay attention to not only latex allergy 
but also fruit allergies with cross-reactivity to latex.  
Up to 2 out of 3 spina bifida patients with natural rubber latex (NRL) antibodies have 
crossreacting IgE-antibody against tropical fruit, due to structural homologies between 
several NRL antigens and allergenic fruit proteins. To investigate whether the patients were 
first sensitized against NRL or fruit, Cremer et al. (2011) investigated sera of 96 patients for 
specific IgE antibody against NRL, banana and kiwi as examples for cross reacting fruit. 
Only two patients developed antibody against fruit without being sensitized against NRL. 
In most cases the sensitization against fruit follows the NRL sensitization. There is no need 
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Allergen cross-reactivity between tobacco and other species of Solanaceae family (tomato, 
potato, aubergine, and egg plant) have been reported. Armentia et al. (2010) have recently 
studied IgE response to tobacco in asthmatic patients sensitized to Lolium perenne 
(Perennial rye grass pollen), and have found that 30% of the tobacco responsive patients also 
have latex sensitization. They concluded that exist cross-reactivity between latex and 
tobacco allergens, and smoker patients with IgE response to tobacco may be a risk 
population for latex sensitization. 
8.2 Gutta-percha and gutta-balata 
In general dental practice, there is over than 30 products containing latex rubber. The 
practitioner should be cautions when threatening patients with a history or allergy to latex 
products. Gutta-percha and gutta-balata, used in endodontic treatment, are derived from 
the Paliquium gutta and Mimusops globsa trees, respectively, that are in the same botanical 
family of the rubber tree Hevea brasiliensis. For this reason immunological cross-reactivity 
between gutta-percha, gutta-balata and NRL were investigated (Costa et al., 2001): no 
detectable cross-reactivity was observed with any of the raw or clinically used gutta-percha 
products. In contrast, gutta-balata released proteins that were cross-reactive with latex. 
Because gutta-balata is sometimes added to commercial gutta percha products, caution 
should be taken if these products are used in endodontic care of latex-allergic individuals.   
Many cases of anaphylaxis reactions occurrence in patient sensitive to latex during 
endodontic treatment has been reported. Boxer et al. (1994) described a latex-allergic dental 
hygienist who experienced immediate lip and gingival swelling and diffuse urticaria after 
the insertion of gutta-percha points into her maxillary molar by a general dentist. 
Immediately after removal of the gutta-percha, relief of the oral discomfort was noted, and 
the urticaria resolved several hours thereafter.  
9. Genetic predisposition 
The intensity of latex exposure, the route of sensitization, the genetically determined 
susceptibility, or the combination of all may have significant influence on pathogenesis of 
type I reaction to latex allergens. Although exposure to NRL products is necessary for 
sensitization, it is not sufficient.  
The field of genome-based medicine, which attempts to identify genetic ffactors some 
individuals have, which may protect them or created problems when they undergo medical 
intervention, is rapidly evolving and affecting all fields of medical practice. Allergic diseases 
are dependent on the specific triggering of IgE-sensitized mast cell and their activation 
resulting in an inflammatory response. Immunological specific mechanism is genetically 
controlled and some individuals are more susceptible to allergic manifestations. Any steps 
of immunological and inflammatory reactions could be involved and are target of 
investigations. Polymorphism in over 30 genes localized on 15 different chromosomes has 
been associated with human allergy. Although the importance of these genetic components 
in the development of allergic diseases, susceptibility genes have been difficult to identify 
given the multigenic nature of this effect. The genetic/ immunologic risk factors of diseases 
susceptibility, that had been most studied, are the classic and non-classic alleles of the Major 
Histocompatibility Complex (MHC), and promoter genes of cytokine polymorphisms. 
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The Major Histocompatibility Complex (MHC), located on chromosome 6p21, is the most 
polymorphic genetic system in mammalians, and has been studied with regard to a wide 
variety of diseases of distinct etiology. The fundamental role of the different molecules 
within the MHC is antigen processing and presentation to the T-cell receptor (TCR), which 
is crucial for the cell interactions in immune response. In humans, while the classic class I 
loci, HLA-A, -B, and -C, bind peptides of intra-cellular origin and present them to CD8 T 
cells, the classic class II loci, HLA-DR, -DQ, and -DP, primarily bind peptides of extra-
cellular origin and present them to CD4 T cells, resulting in cytokine production that drives 
an antibody production. 
Focusing specifically on NRL allergy, Rihs et al. (2002) demonstrated the association 
between the specific IgE response to the major latex allergen hevein (Hev b 6.02) in HCW 
with latex allergy and latex-sensitized patients with spina bifida, and HLA class II alleles of 
DQB1 and DRB1, DRB3, DRB4, and DRB5. The class II HLA-DQB1*03:02 (DQ8) allele and 
HLA-DQB1*03:02 (DQ8)-DRB1*04(DR4) haplotype were significantly involved in the 
hevein-specific IgE immune response in HCW with latex allergy. NRL-sensitized patients 
with spina bifida showed an increase HLA-DQB1*03:02 frequency, but this result was not 
significant. 
Two genes that have been of interest with regard to NRL allergy are IL13 and IL18. IL-13, 
along with IL-4, is critical for the promotion of allergic response. IL-13 plays an important 
role in mediating airway hyperresponsiveness in asthma. Binding of IL-4 and IL-13 to the α 
chain of the IL-4 receptor activates germline transcription of the ε heavy-chain gene locus 
and isotype switching of B cells to IgE production. IL-18 can stimulate interferon production 
or enhance cytokines and IgE production. SNPs in these genes have been postulated to 
influence physiologic functions that are important in development of atopy (Monitto et al., 
2010).  Genetic predisposition to natural rubber latex allergy in the health care workers was 
available, and has been shown to be associated with promoter polymorphisms in IL13 and 
IL18 genes when compared with nonatopic controls (Brown et al., 2005). This association 
was not seen when these patients were genotyped for SNPs in other immunomodulatory 
genes, including IL4, tumor necrosis factor- α and -, CC chemokine receptor 2 and 5, and 
toll-like receptor 4. In patients born with spina bifda and or genitourinary abnormalities the 
association of promoter polymorphisms in IL13 and IL18 genes was not observed (Monitto 
et al., 2010). 
10. Diagnosis of latex allergy  
To manage latex allergy appropriately, prompt and correct diagnosis is essential, and both 
in vivo and in vitro assays have been included. There are two elements to consider in latex 
allergy diagnosis: history and qualitative and quantitative tests. 
10.1 History 
The diagnosis of latex requires a thorough and accurate medical history. Screening patients 
is the first step for minimizing the risk of a latex allergic reaction. It is necessary to have a 
high index of suspicion, especially for patients in high risk occupations or with medical 
histories that induce repeated exposure to latex. Patients at special risk are those individuals 
with frequent or prolonged exposure to latex products. The following points must be 
considered: history of atopy (general allergies); food allergies (especially bananas, kiwi, 
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avocados, chesnut, fig, tomato); history of allergic reactions to latex (including hives, 
swelling, eye/nose symptoms, asthma, and anaphylaxis); and undiagnosed reactions or 
complications during anesthesia, surgery, or dental work. 
The medical clinical history about manifestations is often similar among individuals affected 
by latex allergy. Onset is often insidious with dermatitis of the hands, which patients 
attribute to frequent hand washing and irritation. After a short period of time (less than a 
year) erythema, papulovesiculation, induration, and pruritis emerge within 1-3 hours after 
onset of gloves use. Among HCW, one may often elicit a history of respiratory symptoms, 
which is pronounced while at work. For patients presenting contact dermatitis or urticaria, 
the physician should ask about localization and time of onset of the eruption, morphology, 
nature of progression, and recurrence or periodicity (Woods et al., 1997). 
10.2 Diagnostic testing 
Latex allergy can be diagnosed by skin prick testing, latex-specific serum immunoglobulin E 
testing, glove provocation testing, and patch testing.  Both in vivo and in vitro testing 
methods have been used to diagnose latex allergy with varying degrees of success. 
10.2.1 Skin prick testing (SPT)  
The cutaneous test or skin prick tests with latex extracts are commonly used in the 
diagnostic approach to natural rubber latex allergy. For this, a minute quantity of the 
allergen is introduced into the dermis to cause a reaction with IgE antibodies fixed to 
cutaneous mast cells for release of mediators, producing a visible wheal and erythema. After 
20 minutes the reactions are graded and recorded. The skin of the back or upper arms can be 
used. It should be done by trained allergists in a hospital setting with adequate resuscitation 
and medical support services. Reports of anaphylaxis during SPT for latex allergy 
emphasize the need to safe testing methods for diagnosis. This test has the advantage of 
being sensitive, rapid, and cost-effective. Reactivity in SPT is related to the potency of the 
SPT solution used: as a rule solutions with higher protein and antigen contents gave better 
results. Commercial extracts are used with good specificity and sensivity. Ammoniated and 
non-ammoniated latex extracts and Hev b 1, 2, 3, 4, 6.01, 7.01, and 13 allergens and 
recombinant Hev b 5 (rHev b 5) allergens are commonly used for this purpose. Serial 
dilutions extracts and NRL allergens were employed in skin testing. It is important to 
consider that sensitivity and specificity of different commercially available skin prick tests 
could vary (Bernardini et al., 2008b; van Kampen et al., 2010).   
10.2.2 In vitro assays for latex-specific IgE 
Quantitative measurement of allergen-specific IgE antibodies in serum requires special 
methods to detect the extremely minute quantities (pictograms per milliliter) found in 
allergic patients. Sensitive and specific commercial in vitro serological assays that have been 
developed for the diagnosis of IgE-mediated latex allergy include a radioallergosorbent 
assay – RAST, and enzyme-immunoassay method - ELISA. These occur in a 2-phase 
(solid/liquid) system using an insolubilized allergen that is incubated first in the test serum 
to react with latex specific IgE and then in radio, fluoro or enzyme- labeled heterologous 
anti-human IgE isotype. These tests require purified preparations of allergens (Hev b 1, Hev 
b 3, Hev b 5 - rHev b 5, Hev b 6.02, Hev b 8, and Hev b 13) and anti-human IgE. The 
differences in preparations of latex allergen and the existence of possible cross-reacting 
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antibodies contribute to variance in accuracy of these tests. In atopic individuals, especially 
in patients with allergies to fruits or vegetables, these serological tests can produce false- 
positive results. The diagnostic sensitivity and specificity of the latex-specific IgE serology 
can be less when compared with skin tests (Smith et al., 2007). 
10.2.3 Microarray technology 
Microarray technology has recently been introduced being a reliable tool for diagnosing 
latex allergy (Ebo et al., 2010; Ott et al., 2010). A positive specific IgE (sIgE) result for latex 
does not always mirror the clinical situation and is frequently found in individuals without 
overt latex allergy. The diagnosis of latex allergy could be established by the combination of 
recombinant latex components present on the microarray (Hev b 1, Hev b 3, Hev b 5 and 
Hev b 6.02).  The reaction can be performed with different platforms, the ImmunoCAP ISAC 
microarray and traditional singleplexed ImmunoCAP. Microarray can improve the 
diagnosis of IgE-mediated latex allergy by discriminating between genuine allergy and 
sensitization. 
10.2.4 Provocation test  
Occasionally, it is desirable to test the target (cutaneous, respiratory, or gastrointestinal) 
tissue responsiveness to the allergen under controlled conditions. Cutaneous provocation 
tests have been used in patients with suspect latex allergy: they wore a latex glove on one 
hand and a vinyl glove on the other hand for 15 minutes. Sensitivity is 90%, but some 
studies have indicated it may be more dangerous than skin testing in very allergic 
individuals. In the nasal provocation test, changes in nasal airways resistance and visible 
signs of congestion and rhinorrhea are observed after exposure to quantitative allergen 
challenge. To examine the responses in patients with positive SPT to nasal provocation test, 
Unsel et al. (2009) found that nasal provocation test has a sensitivity of 96%, specificity of 
100%, negative predictive value of 98% and positive predictive value of 100%. 
10.2.5 Path testing 
Path testing is helpful in differentiating irritant contact dermatitis from allergic contact 
dermatitis mediated by type IV hypersensitivity reactions. It’s a definitive test for diagnosis 
of patients with type IV hypersensitivity to latex products using a standard battery of 
rubber additives. The series of rubber allergen were applied on normal skin, usually on the 
patient’s back or arms, under a small semi occlusive dressing. It is left in place for 24-48 
hours. The results are first read in 30 minutes after removing patches, and again 24 or 48 h. 
The positive reaction can be accepted as the cause of the present eruption. Accelerators 
evoke positive patch tests in 82% patients with occupationally induced contact dermatitis 
associated with glove use. The allergens that most commonly yielded positive reactions 
have been carbamates, 4,4-dithiodimorpholine, thiurams mix, 2-mercaptobenzothiazole, and 
1,3-diphenylguanidine (Woods et al., 1997; Bendewald et al., 2010; Cao et al., 2010). 
11. Management and treatment 
At present, latex avoidance is the only available treatment and has been the key to 
preventing allergic reactions in latex-sensitized individuals. For patients, avoidance of 
exposure to the allergen is essential to minimizing perioperative complications (Heitz & 
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Bader, 2010). In 1998, the Food and Drug Administration (FDA) started to require the 
labeling of medical devices made from rubber latex; since that time substantial progress had 
been made in identifying latex-free alternatives. 
Avoidance of exposure to allergen is essential to minimizing complications in patients 
suspected to be at risk. The patient must be aware of the long list of medical and consumer 
products containing latex. Because there is cross reactivity between latex and fruit antigens, 
patients should be careful when first consuming these fruits after diagnosis. Procedures 
performed on latex-sensitive patients should be performed in latex-safe environment. A 
latex-safe environment is one in which no latex gloves are used; in addition, there must be 
no latex accessories (masks, rebreathing, cannulas, catheters, adhesives, tourniquets, 
anesthesia equipment) that come in direct contact with the patients. Prophylactic 
premedication is used by many centers for surgical patients with high risk of latex allergy. 
The use must be begin 24 h before surgery. In cases of minor reactions, such as contact 
dermatitis, the gloves should be removed immediately. For severe cases involving pruritus 
and erythema, therapy with H1 antagonists should be initiated; H2 blockers also can be used. 
In cases of severe systemic anaphylaxis, initial attention should focus on pulmonary and 
cardiovascular manifestations of the reaction, because these are the major causes of death. 
The health care workers with latex allergy must be protected from adverse reaction to latex. 
Sensitization to latex antigens is commonly encountered in HCW wearing latex gloves with 
high latex allergen concentrations and in workers wearing powdered latex surgical gloves. 
HCW who have contact dermatitis to latex products can avoid it by changing to a different 
brand of gloves like vinyl and other synthetic gloves. Workers with a documented type I 
latex allergy must be protected from serious systemic reactions. Basically this involves latex 
avoidance. Low-protein, in powder-free gloves, decreases the sensitization potential of the 
latex and avoids some of the granuloma associated with the powder. Latex proteins are 
adsorbed by glove powder and may be airbone and the use of powder-free gloves can 
sometimes reduce the aerosol levels. In a review of claims data from 1997 to 2005 about the 
switch to powder-free latex gloves, Malerich et al. (2008) concluded that it was associated 
with a significant decrease in workers' compensation for latex-related illness. The cost of 
gloves increased but was partially offset by a decrease in workers' compensation payments 
and operating room expenses.  
Future strategies must focus not only on the reduction of allergens during latex manufacture 
and development of suitable non-latex gloves, but also the immunotherapy including 
desensitization of latex allergic individuals and development of candidate vaccine (Belleri & 
Crippa, 2008; Bernardini et al., 2008a; Rolland & O'Hehir, 2008; Nettis et al., 2010). 
In allergy desensitization treatment, the immune response itself can be altered. In practice, 
true desensitization is rare: specific IgE- mediated allergy is significantly lessened but not 
eliminated, even after many years of treatment. Immunological changes during 
desensitization therapy for IgE- mediated disease consist of increased IgG antibody levels 
and decreased IgE production. IgG are called “blocking antibody”. Sublingual 
immunotherapy (SLIT) with natural rubber latex (NRL) has recently been proposed and was 
safe and effective; no SLIT-related side effects had been observed. Bernardini et al. (2008a) 
used commercial latex SLIT in pediatric patients and observed the effect for three years. A 
significant reduction of the glove-use score was observed after 1, 2, and 3 years of treatment 
with SLIT. Baseline wheal areas of skin prick test and baseline values of serum specific IgE 
were significantly reduced. They concluded that three years of latex SLIT is safe, and it 
consolidates the efficacy of treatment in pediatric patients. In addition, current 
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subcutaneous immunotherapy schedules have been tested for treatment of latex allergy with 
evidence of efficacy, but the risks of adverse events have been high.  
For such potent allergens as latex, hypoallergenic but T cell-reactive preparations are 
required for clinical use. For this, it is essential to identify allergenic components of latex 
products with generation of monoclonal antibodies and recombinant allergens, allowing 
sequence determination and mapping of T cell and B cell epitopes. Potential hypoallergenic 
latex preparations identified include modified non-IgE-reactive allergen molecules and 
short T cell epitope peptides. Together, these reagents and data should facilitate improved 
diagnostics and investigation of novel-specific therapeutics. The co-administration of 
adjunct therapies, such as anti-IgE or corticosteroids, and appropriate adjuvant for 
induction of regulatory T cell response offer promise for clinically effective, and 
development of safe latex-specific candidate vaccines. 
12. Conclusion 
Latex products have had many useful roles in the medical fields. Unfortunately the allergic 
responses to latex have become causes of both morbidity and mortality. Avoidance of 
exposure to allergen is essential to minimizing complications in patients suspected to be at 
risk, butthere is lack of information concerning latex allergen content of medical equipment  
leading to an increased risk to sensitized patients. Occupational health need to be a 
guideline and should be prepared for any emergency. Patients with well documented latex 
hypersensitivity can undergo surgical procedures with proper panning and care. Further 
strategies must be focused not only on the reduction of allergens during latex manufacture 
and development of suitable non-latex gloves, but also on the immunotherapy and 
development of vaccine. 
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